Navigation Links
South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeam™ Radiotherapy System from Varian Medical Systems
Date:8/5/2011

BOCA RATON and JUPITER, Fla., Aug. 5, 2011 /PRNewswire/ -- In a promising development for cancer patients in The Palm Beach area, South Florida Radiation Oncology announced today that it has acquired the TrueBeam system, an innovative system that enables a radically different approach to treating cancer with image-guided radiotherapy.

The TrueBeam system, from Varian Medical Systems, was engineered from the ground up to deliver more powerful cancer treatments with pinpoint accuracy and precision. It uniquely integrates new imaging and motion management technologies within a sophisticated new architecture that makes it possible to deliver treatments more quickly while monitoring and compensating for tumor motion, opening the door to new possibilities for the treatment of lung, breast, prostate, head and neck, as well as other cancers that are treatable with radiotherapy.  South Florida Radiation Oncology is the only cancer center in the palm beaches and the treasure coast with the TrueBeam system and is now available in both the Boca and Jupiter location.

"TrueBeam is a real game-changer that will enable us to treat even the most challenging cases with unprecedented speed and precision," said Ben Han, MD, Radiation Oncologist. "With a broad spectrum of new capabilities, TrueBeam breaks the mold in just about every dimension, making it possible for us to offer faster, more targeted treatments to tumors even as they move and change over time.  We are very excited to be the first radiation oncology center in Florida to offer this amazingly precise treatment."

High Speed Treatments

With dose delivery rates that are 40–140 percent higher than earlier generations of Varian technology, the TrueBeam system can complete a treatment faster. This makes it possible to offer greater patient comfort by shortening treatments, and to improve precision by leaving more time for tumor targeting accurately. "Intuitive" automation further speeds treatments with an up to fivefold reduction in the number of steps needed for image guidance and dose delivery.

Simple treatments that once took 15 minutes or more can be completed in less than two once the patient is in position. "These are significant reductions in treatment time," said Dr. Eugene Shieh, Radiation Oncologist.

Enhanced Precision

TrueBeam can be used for radiotherapy treatments including image-guided radiotherapy and radiosurgery (IGRT and IGRS), intensity-modulated radiotherapy (IMRT), RapidArc® radiotherapy and gated RapidArc.

The precision of the TrueBeam system is measured in increments of less than a millimeter. This accuracy is made possible by the system's sophisticated architecture, which synchronizes imaging, patient positioning, motion management, beam shaping and dose delivery, performing accuracy checks every ten milliseconds throughout the entire treatment.  Critical data points are measured continually as a treatment progresses, ensuring that the system maintains a "true isocenter," or focal point of treatment.

For lung and other tumors subject to respiratory motion, TrueBeam offers gated RapidArc® radiotherapy, which makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering dose during a continuous rotation around the patient.  "During the last decade, lung cancer became the leading cause of cancer death for both men and women in the United States," said Drs Han and Shieh. "With TrueBeam, we can treat a moving lung tumor as if it were standing still(1).  We expect this to make a meaningful difference for lung cancer patients in the area."

"With TrueBeam, we can select the optimal treatment for every type of cancer," said Dr. Ben Han, MD. "This is a breakthrough that lets us bring a wider spectrum of advanced radiotherapy treatment options to many more patients. It represents a quantum leap in our ability to help people fight cancer."

(1)  Underberg Rene WM et al. A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer. Radiat Oncol. 2006; 1: 8.

FOR INFORMATION CONTACT:
Ravi Patel, CEO; (877) 930-7376
rpatel@sfrollc.com


'/>"/>
SOURCE South Florida Radiation Oncology
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
2. Artists for a New South Africa Will be Shaking The Blues at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb Mo, Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles
3. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
4. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
5. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
6. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
7. Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities
8. DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties
9. Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea
10. Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network
11. Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017 DaVita Inc. (NYSE: DVA ) ... 31, 2016. Net income attributable to DaVita ... was $158 million, or $0.80 per share and $880 million, ... income attributable to DaVita Inc. for the quarter and year ... was $192 million, or $0.98 per share, and $789 million, ...
(Date:2/16/2017)... 16, 2017  Newly published research from the CVS ... the role a private retailer can play in restricting ... published online today in the American Journal of ... remove tobacco from all CVS Pharmacy stores reduced the ... an even greater impact on those who bought cigarettes ...
(Date:2/16/2017)... -- Prescription pain medications provided by "physicians in the months ... opioid use to take hold," according to a new ... The New England Journal of Medicine (NEJM). ... acute pain than in almost any other medical setting," ... the American College of Emergency Physicians. "The challenge is ...
Breaking Medicine Technology:
(Date:2/18/2017)... ... February 18, 2017 , ... ProParagraph Fashion ... Film Studios ’ ProParagraph Fashion Volume 2 for all multi-line FCPX project needs. ... Users can pick and choose from hand-crafted trend-setting designs with smooth animations that ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one ... in the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare ... is recognized across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... Chief Executive Officer, George Rogers, was named to Staffing Industry Analysts' 2017 "Staffing ... 100 honors those who have made notable contributions to the staffing industry over ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... services and financial planning assistance to families and business owners in the greater ... LifeNet 4 Families organization. , For more than 30 years, LifeNet 4 ...
Breaking Medicine News(10 mins):